Search research articles
Contact Us
Filters
Showing results (111-120 of 121) with videos related to
Page
of 13
Sort By:
The American Journal of Cardiology
|
January 19, 1995
Safety and efficacy of epoprostenol in patients with severe congestive heart failure. Epoprostenol Multicenter Research Group
C A Sueta, M Gheorghiade, K F Adams, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
May 1, 1992
Cardiac events after heart transplantation: incidence and predictive value of coronary arteriography
B F Uretsky, R L Kormos, T R Zerbe, et al.
Clinical Transplants
|
January 1, 1991
Cardiac transplantation at the University of Pittsburgh: 1980 to 1991
R L Kormos, J M Armitage, R L Hardesty, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
July 1, 1992
Utility of prostaglandin E1 in the pretransplantation evaluation of heart failure patients with significant pulmonary hypertension
S Murali, B F Uretsky, J M Armitage, et al.
The American Journal of Cardiology
|
May 1, 1992
Potential limitations of percutaneous transluminal coronary angioplasty in heart transplant recipients
J S Sandhu, B F Uretsky, P S Reddy, et al.
JAMA
|
July 20, 1999
Queuing for coronary angiography during severe supply-demand mismatch in a US public hospital: analysis of a waiting list registry
S Rosanio, M Tocchi, D Cutler, et al.
American Heart Journal
|
July 1, 1999
Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST)
C M O'Connor, W A Gattis, B F Uretsky, et al.
American Heart Journal
|
July 1, 1997
A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST)
R M Califf, K F Adams, W J McKenna, et al.
Circulation
|
December 1, 1996
Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group
W S Colucci, M Packer, M R Bristow, et al.
The New England Journal of Medicine
|
February 1, 1996
A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension
R J Barst, L J Rubin, W A Long, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 121) with videos related to
Sort By:
Page
of 13
The American Journal of Cardiology
|
January 19, 1995
Safety and efficacy of epoprostenol in patients with severe congestive heart failure. Epoprostenol Multicenter Research Group
C A Sueta, M Gheorghiade, K F Adams, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
May 1, 1992
Cardiac events after heart transplantation: incidence and predictive value of coronary arteriography
B F Uretsky, R L Kormos, T R Zerbe, et al.
Clinical Transplants
|
January 1, 1991
Cardiac transplantation at the University of Pittsburgh: 1980 to 1991
R L Kormos, J M Armitage, R L Hardesty, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
July 1, 1992
Utility of prostaglandin E1 in the pretransplantation evaluation of heart failure patients with significant pulmonary hypertension
S Murali, B F Uretsky, J M Armitage, et al.
The American Journal of Cardiology
|
May 1, 1992
Potential limitations of percutaneous transluminal coronary angioplasty in heart transplant recipients
J S Sandhu, B F Uretsky, P S Reddy, et al.
JAMA
|
July 20, 1999
Queuing for coronary angiography during severe supply-demand mismatch in a US public hospital: analysis of a waiting list registry
S Rosanio, M Tocchi, D Cutler, et al.
American Heart Journal
|
July 1, 1999
Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST)
C M O'Connor, W A Gattis, B F Uretsky, et al.
American Heart Journal
|
July 1, 1997
A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST)
R M Califf, K F Adams, W J McKenna, et al.
Circulation
|
December 1, 1996
Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group
W S Colucci, M Packer, M R Bristow, et al.
The New England Journal of Medicine
|
February 1, 1996
A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension
R J Barst, L J Rubin, W A Long, et al.
Page
of 13